日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

帕博西尼与质子泵抑制剂在早期乳腺癌中的药物相互作用:PALLAS(ABCSG-42/AFT-05/BIG-14-13/PrE0109)探索性分析

Agostinetto, E; Pfeiler, G; Hlauschek, D; Mayer, E L; Lambertini, M; de Azambuja, E; Bellet-Ezquerra, M; Meisel, J L; Rubovszky, G; Zdenkowski, N; Novik, Y; Ruiz-Borrego, M; Gelmon, K A; Mamounas, E P; Iwata, H; Lu, D R; Soelkner, L; Fesl, C; Gnant, M; DeMichele, A

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)

在早期乳腺癌患者中,帕博西尼联合辅助内分泌治疗的 PALLAS 随机试验中的生活质量和症状严重程度(AFT-05、ABCSG-42、BIG-14-03、PrE0109)

Naughton, M J; Zahrieh, D M; Gnant, M; Zdenkowski, N; Lemieux, J; Mao, J J; Bjelic-Radisic, V; Shinn, E; Balic, M; Thomssen, C; Meisel, J L; Ruiz, G M; Loibl, S; Isaacs, C; Cameron, D; Henao-Carrasco, F M; Goetz, M P; Singer, C F; Werutsky, G; Rugo, H S; Vetter, M; Tseng, L-M; Miller, K; Fitzal, F; Gil Gil, J M; Park, H; Linderholm, B; Bajetta, E; Dayao, Z; Prat, A; Ehrhardt, K; Metzger, O; Arahmani, A; Law, E H; Partridge, A H; Carey, L A; Zoroufy, A; Dueck, A C; O'Brien, P; Hlauschek, D; DeMichele, A; Mayer, E L

A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials

新辅助全身性乳腺癌治疗试验中局部区域治疗报告的核心结果集

Potter, Shelley; Avery, Kerry; Ahmed, Rosina; de Boniface, Jana; Chatterjee, Sanjoy; Dodwell, David; Dubsky, Peter; Federmann, Jingjing; Finestone, Sandra; Gnant, Michael; Hlauschek, Dominik; Iwata, Hiroji; Jiang, Michael Y; Kaidar-Person, Orit; Lee, Han-Byoel; MacKenzie, Mairead; Meyn, Anne; Poortmans, Philip; Poulakaki, Fiorita; Richardson, Andrea L; Sepulveda, Karla A; Spillane, Andrew J; Thompson, Alastair M; Werutsky, Gustavo; Wittmann, Philipp; Wright, Jean L; Zdenkowski, Nicholas; Cowan, Katherine; McIntosh, Stuart A

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])

PALLAS试验中IIA期与IIB/III期患者的结局[ABCSG-42/AFT-05/PrE0109/BIG-14-13])

DeMichele, A; Dueck, A C; Hlauschek, D; Martin, M; Burstein, H; Pfeiler, G; Zdenkowski, N; Wolff, A; Bellet-Ezquerra, M; Winer, E; Balic, M; Miller, K; Colleoni, M; Lake, D; Rubovsky, G; Cameron, D; Balko, J; Singer, C F; Nowecki, Z; Iwata, H; Wolmark, N; Parraga, K A; Rugo, H; Steger, G G; Traina, T; Werutsky, G; Czajkowska, D; Metzger, O; El-Abed, S; Theall, K P; Lu, R D; O'Brien, P; Fesl, C; Mayer, E; Gnant, M

Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial

利用治疗药物监测评估 5-氟尿嘧啶的可行性和人群暴露量(PREDICT-5FU):一项多中心临床试验

Glewis, Sarah; Michael, Michael; Gurney, Howard; Olver, Ian; Zdenkowski, Nicholas; Ackland, Stephen; Kukard, Craig; Jayawardana, Madawa; Silva, S Sandun M; Alexander, Marliese; Tie, Jeanne; Galettis, Peter; Martin, Jennifer H

Risk of Cancer Recurrence Exerts the Strongest Influence on Choice Between Active Surveillance and Thyroid Surgery as Initial Treatment for Low-Risk Thyroid Cancer: Results of a Discrete Choice Experiment

癌症复发风险对低风险甲状腺癌初始治疗方案的选择(主动监测或甲状腺手术)影响最大:一项离散选择实验的结果

Hampton, Jacob; Cooper, Gavin; Wall, Laura; Rowe, Christopher; Zdenkowski, Nicholas; Fradgley, Elizabeth; Miller, Julie; Gough, Jenny; Brown, Scott; O'Neill, Christine

Development of a Decision Aid for Patients With Low-Risk Thyroid Cancer: A Mixed-Methods Analysis of Feedback From Both Patient and Clinicians

为低风险甲状腺癌患者开发决策辅助工具:一项基于患者和临床医生反馈的混合方法分析

O'Neill, Christine J; Alam, Ahmad; Chapman, Michelle; Carlson, Melissa; Clark-Pitrolo, Suzanne; Fradgley, Elizabeth A; Paul, Christine; Zdenkowski, Nicholas; Rowe, Christopher W

Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project

新辅助全身性乳腺癌治疗试验中局部区域治疗核心结局指标集制定及报告指南方案:PRECEDENT项目

Potter, Shelley; Avery, Kerry; Ahmed, Rosina; de Boniface, Jana; Chatterjee, Sanjoy; Dodwell, David; Dubsky, Peter; Iwata, Hiroji; Jiang, Michael; Lee, Han-Byoel; MacKenzie, Mairead; Poulakaki, Fiorita; Richardson, Andrea L; Sepulveda, Karla; Spillane, Andrew; Thompson, Alastair M; Werutsky, Gustavo; Wright, Jean L; Zdenkowski, Nicholas; Cowan, Katherine; McIntosh, Stuart

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology

澳大利亚基于区域性的转化癌症研究合作项目运用FAIT方法的影响

Paul, Christine L; Verrills, Nicole M; Ackland, Stephen; Scott, Rodney; Goode, Susan; Thomas, Ann; Lukeman, Sarah; Nielsen, Sarah; Weidenhofer, Judith; Lynam, James; Fradgley, Elizabeth A; Martin, Jarad; Greer, Peter; Smith, Stephen; Griffin, Cassandra; Avery-Kiejda, Kelly A; Zdenkowski, Nick; Searles, Andrew; Ramanathan, Shanthi

Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

在帕博西尼联合辅助内分泌治疗激素受体阳性/人表皮生长因子受体 2 阴性早期乳腺癌的帕博西尼辅助治疗研究中,治疗暴露和停药情况 (PALLAS/AFT-05/ABCSG-42/BIG-14-03)

Mayer, Erica L; Fesl, Christian; Hlauschek, Dominik; Garcia-Estevez, Laura; Burstein, Harold J; Zdenkowski, Nicholas; Wette, Viktor; Miller, Kathy D; Balic, Marija; Mayer, Ingrid A; Cameron, David; Winer, Eric P; Ponce Lorenzo, José Juan; Lake, Diana; Pristauz-Telsnigg, Gunda; Haddad, Tufia C; Shepherd, Lois; Iwata, Hiroji; Goetz, Matthew; Cardoso, Fatima; Traina, Tiffany A; Sabanathan, Dhanusha; Breitenstein, Urs; Ackerl, Kerstin; Metzger Filho, Otto; Zehetner, Karin; Solomon, Kadine; El-Abed, Sarra; Theall, Kathy Puyana; Lu, Dongrui Ray; Dueck, Amylou; Gnant, Michael; DeMichele, Angela